Online ISSN: 3007-0244,
Print ISSN:  2410-4280
СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ ОБ АУТОИММУННОМ ГЕПАТИТЕ
Просмотреть статью в архиве
В статье представлены современные представления о диагностике и лечении аутоиммунного гепатита.
Жумадилова З.К., Муздубаева Ж.Е., Каскабаева А.Ш., Кусаинова А.А. Государственный медицинский университет города Семей, Казахстан
1. Waldenstrom J. Leber, Blutproteine und Nahrungsei-weiss. Dt Sch Ges Verd Stoffw. 1950; 15: 113-21. 2. Johnson Ph.J., Mc FarlaneI.G. Meeting report: Inter-national Autoimmune Hepatitis Group. Hepatology.1993; 18: 998-1005. 3. Vento S., Garofano T., Di Perri G. et al.Identification of hepatitis A virus as a trigger for autoimmune chronic active hepatitis type 1 in susceptible individuals.Lancet.1991; 337: 1183-7. 4. Rahaman S.M., Chira P., Koff R. S. Idiopatic auto-immune chronic hepatitis triggered by hepatitis A. Am J Gastroenterol. 1994; 89: 106-8 5. Robertson D.A.F., Zhang S.L., Guy E.C., Wright R. Persistent measles virus genome in autoimmune chronic active hepatitis. Lancet.1987; 2: 9-11. 6. Vento S., Guella L., Mirandola F. еtal. Epstein-Barr virus a trigger for autoimmune hepatitis in susceptible indi-viduals. Lancet.1995; 346: 608-9. 7. Garcia-Buey L., Garcia-Monzon C., Rodrigues S. etal. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterolo-gy.1995; 108: 1770-7. 8. Czaja A.J. Autoimmune hepatitis: evolving concepts and treatment strategies. Dig Dis Sci. 1996; 40: 435-56. 9. Johnson Ph. J., Mc Farlane I.G., Williams R. Azathi-oprine for long-term maintenance of remission in autoim-mune hepatitis. N Engl J Med. 1995; 333: 958-63. 10. Nouri-Aria K.T.N., Hegarty J.E., Alexander G.J.M. et al. Effect of corticosteroid on supressor-cell activity in “auto-immune” and viral chronic active hepatitis. N Engl J Med. 1982; 307: 1301-4. 11. Sanchez-Urdazpal L.S., Czaja A.J., van Hock B. et al. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology.1992; 15: 215-21. 12. Stellon A.G., Keating J.J., Johnson Ph. J. et al. Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology.1988; 8: 781-4. 13. Feldman M, Friedman L.S, Sleisenger M.H. Gastro-intestinal and Liver Disease, 7th Edition, Saunders 2003, Philadelfia. 14. Czaja A.J, Menon K.V.N, Carpenter H.A. Sustained remission after corticosteroid therapy for autoimmune hepa-titis: a retrospective analysis. Hepatology 2002;35:890–97. 15. Hegarty J.E., Nouri-Aria K.T.N., Portmann B. et al. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatolody.1983; 3: 685-89. 16. Vierling J.M, Flores P.A. Evolving new therapies of autoimmune hepatitis.Clin Liver Dis 2002;6:825–50. 17. Alvarez F, Ciocca M., Canero-Velasco C. Short – term cyclosporine induces a remission of autoimmune hep-atitis in children. J Hepatol 1999; 30:222–7. 18. Malekzadeh R., Nasser-Moghaddam S., Kaviani M.J. Cyclosporin–А is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 2001;46:1321–27. 19. Aqel B.A, Machicao V, Rosser B. Efficaсy of tacro-limus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol 2004;38:805–09. 20. RichardsonP.D, James P.D, Ryder S.D. Mycophe-nolate mofetil for maintenance of remission in autoimmune hepatitis patients resistant to or intolerant of azathioprine. J Hepatol 2000;33: 371–75. 21. Devlin S.M., Swain M.G., Urbansky S.J. Mycophe-nolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standart therapy. Can J Gastroenterol 2004;18:312–26. 22. Czaja A.J., Carpenter H.A. Empiric therapy of auto-immune hepatitis with mycofenolatе mofetil: comparison with conventional treatment for refractory disease. J Clin Gastroenterol (in press). 23. Czaja A.J., Lindor K.D. Failure of budesonide in a pilot study of treatment – dependent autoimmune hepatitis. Gastroenterology 2000;119: 1312–16. 24. Feldman M., Friedman L.S., Sleisenger M.H. Gas-trointestina land Liver Disease, 7thEdition, Saunders 2003, Philadelfia. 25. Acute and chronic liver diseases: Immunologic mechanisms and therapy. Postgraduate Course of ASLD. 2005, - Р. 139-46.
Количество просмотров: 738

Ключевые слова:

Категория статей: Статьи

Библиографическая ссылка

Жумадилова З.К., Муздубаева Ж.Е., Каскабаева А.Ш., Кусаинова А.А. СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ ОБ АУТОИММУННОМ ГЕПАТИТЕ // Наука и Здравоохранение 2014.№ 2. С.42-44 Zhumadilova Z.K., Muzdubayeva Zh.E., Kaskabayeva A.Sh., Kussainova A.A. MODERN CONCEPT OF AUTOIMMUNE HEPATITIS // Nauka i Zdravookhranenie. 2014.№ 2. С. 42-44 Жұмаділова З.К., Муздубаева Ж.Е., Қасқабаева А.Ш., Қусаинова А.А. АУТОИММУНДЫ ГЕПАТИТ ТУРАЛЫ ҚАЗІРГІ КҮНГІ КӨЗҚАРАС // Ғылым және Денсаулық сақтау 2014.№ 2. С. 42-44

Авторизируйтесь для отправки комментариев